Spots Global Cancer Trial Database for prostate specific antigen
Every month we try and update this database with for prostate specific antigen cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD | NCT00378690 | Prostate Cancer | leuprorelin ace... | 18 Years - 80 Years | Astellas Pharma Inc | |
| Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA | NCT01681823 | Prostatic Neopl... | PectaSol-C Modi... | 21 Years - | EcoNugenics | |
| Dissemination of Prostate Cancer Screening to PCP's in African American Communities | NCT00629330 | Prostate Cancer | Academic Detail... | 45 Years - 75 Years | Columbia University | |
| A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer | NCT01685983 | Prostate Cancer | Abiraterone ace... Prednisolone | 18 Years - | Janssen Research & Development, LLC | |
| Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer | NCT00861471 | Prostate Cancer Prostatic Neopl... | Docetaxel Imatinib Mesyla... | 18 Years - | NYU Langone Health | |
| Green Tea Extract and Prostate Cancer | NCT00676780 | Prostate Cancer | Polyphenon E (E... | 18 Years - 75 Years | Louisiana State University Health Sciences Center Shreveport | |
| MRI Versus PSA in Prostate Cancer Screening | NCT02799303 | Prostate Cancer | Multi-parametri... PSA testing | 50 Years - | Sunnybrook Health Sciences Centre | |
| Prostate Cancer Stereotactic Radiotherapy | NCT02319239 | Prostate Neopla... Toxicity Due to... | Fractionation hypofractionate... stereotactic fr... | 30 Years - | Tampere University Hospital | |
| A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy | NCT01302041 | Prostate Cancer | Enzalutamide | 18 Years - | Astellas Pharma Inc | |
| Study of CEP-701 in Treatment of Prostate Cancer | NCT00081601 | Prostate Cancer | CEP-701 | 18 Years - | Teva Branded Pharmaceutical Products R&D, Inc. | |
| Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy | NCT00850941 | Prostate Cancer | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma | NCT00001266 | Prostatic Neopl... | Suramin | - | National Institutes of Health Clinical Center (CC) | |
| A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer | NCT01337518 | Prostatic Neopl... | EZN-4176 | 18 Years - | Enzon Pharmaceuticals, Inc. | |
| Changing of Prostate Specific Antigen Value in Patients With Covid-19 | NCT05009186 | Covid19 Prostate Specif... | PSA value | 45 Years - 70 Years | Saglik Bilimleri Universitesi | |
| Changing of Prostate Specific Antigen Value in Patients With Covid-19 | NCT05009186 | Covid19 Prostate Specif... | PSA value | 45 Years - 70 Years | Saglik Bilimleri Universitesi | |
| TKI258 in Castrate Resistant Prostate Cancer | NCT00831792 | Prostate Cancer | TK1258 | - | M.D. Anderson Cancer Center | |
| A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer | NCT01685983 | Prostate Cancer | Abiraterone ace... Prednisolone | 18 Years - | Janssen Research & Development, LLC | |
| Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy | NCT00126815 | Prostate Cancer | - | AHS Cancer Control Alberta | ||
| TKI258 in Castrate Resistant Prostate Cancer | NCT00831792 | Prostate Cancer | TK1258 | - | M.D. Anderson Cancer Center | |
| Study of CEP-701 in Treatment of Prostate Cancer | NCT00081601 | Prostate Cancer | CEP-701 | 18 Years - | Teva Branded Pharmaceutical Products R&D, Inc. | |
| Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a | NCT02381015 | Prostate Cancer Prostate Cancer... Hereditary Pros... | Genetic Risk Sc... Genetic Risk Sc... Family History:... Family History:... | 40 Years - 49 Years | NorthShore University HealthSystem | |
| MRI Versus PSA in Prostate Cancer Screening | NCT02799303 | Prostate Cancer | Multi-parametri... PSA testing | 50 Years - | Sunnybrook Health Sciences Centre | |
| A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD | NCT00378690 | Prostate Cancer | leuprorelin ace... | 18 Years - 80 Years | Astellas Pharma Inc | |
| Green Tea Extract and Prostate Cancer | NCT00676780 | Prostate Cancer | Polyphenon E (E... | 18 Years - 75 Years | Louisiana State University Health Sciences Center Shreveport | |
| Study of Metformin With Simvastatin for Men With Prostate Carcinoma | NCT01561482 | Prostate Carcin... | Metformin Simvastatin | 18 Years - | Baylor College of Medicine | |
| Prostate Cancer Stereotactic Radiotherapy | NCT02319239 | Prostate Neopla... Toxicity Due to... | Fractionation hypofractionate... stereotactic fr... | 30 Years - | Tampere University Hospital | |
| Green Tea Extract and Prostate Cancer | NCT00676780 | Prostate Cancer | Polyphenon E (E... | 18 Years - 75 Years | Louisiana State University Health Sciences Center Shreveport | |
| Study of CEP-701 in Treatment of Prostate Cancer | NCT00081601 | Prostate Cancer | CEP-701 | 18 Years - | Teva Branded Pharmaceutical Products R&D, Inc. | |
| Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer | NCT00861471 | Prostate Cancer Prostatic Neopl... | Docetaxel Imatinib Mesyla... | 18 Years - | NYU Langone Health | |
| Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy | NCT00126815 | Prostate Cancer | - | AHS Cancer Control Alberta | ||
| Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance | NCT03579654 | Prostate Cancer | Proscavax | 18 Years - | OncBioMune Pharmaceuticals |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
